Circulating biomarkers of collagen metabolism in cardiac diseases.
about
A reappraisal of loop diuretic choice in heart failure patientsFibrosis-related biomarkers and risk of total and cause-specific mortality: the cardiovascular health studyMatricellular proteins and matrix metalloproteinases mark the inflammatory and fibrotic response in human cardiac allograft rejection.Early change of extracellular matrix and diastolic parameters in metabolic syndrome.Rationale and design of the Multidisciplinary Approach to Novel Therapies in Cardiology Oncology Research Trial (MANTICORE 101--Breast): a randomized, placebo-controlled trial to determine if conventional heart failure pharmacotherapy can prevent trFibrosis-related biomarkers and incident cardiovascular disease in older adults: the cardiovascular health study.Left ventricular diastolic function in relation to the urinary proteome: a proof-of-concept study in a general population.Left Ventricular Dysfunction and CXCR3 Ligands in Hypertension: From Animal Experiments to a Population-Based Pilot StudyCirculating annexin A5 levels after atrial switch for transposition of the great arteries: relationship with ventricular deformation and geometryCell death and serum markers of collagen metabolism during cardiac remodeling in Cavia porcellus experimentally infected with Trypanosoma cruziMyocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy.Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatmentThe cardiokine story unfolds: ischemic stress-induced protein secretion in the heartThe N-terminal propeptide of type III procollagen in patients with acute coronary syndrome: a link between left ventricular end-diastolic pressure and cardiovascular events.Clinical significance of markers of collagen metabolism in rheumatic mitral valve disease.Polarization second harmonic generation microscopy provides quantitative enhanced molecular specificity for tissue diagnostics.The inflammatory response in myocardial injury, repair, and remodelling.Cardiac microinjury measured by troponin T predicts collagen metabolism in adults aged >=65 years with heart failure.Safety of daily teriparatide treatment: a post hoc analysis of a Phase III study to investigate the possible association of teriparatide treatment with calcium homeostasis in patients with serum procollagen type I N-terminal propeptide elevation.Calibrated integrated backscatter and myocardial fibrosis in patients undergoing cardiac surgeryProcollagen C-Proteinase Enhancer 1 (PCPE-1) as a Plasma Marker of Muscle and Liver Fibrosis in MiceUrinary proteomic profiling in severe obesity and obstructive sleep apnoea with CPAP treatment.Circulating multimarker profile of patients with symptomatic heart failure supports enhanced fibrotic degradation and decreased angiogenesis.Aldosterone, mineralocorticoid receptor activation, and cardiovascular remodeling.Cardiac-Secreted Factors as Peripheral Metabolic Regulators and Potential Disease Biomarkers.Associations between metabolic dysregulation and circulating biomarkers of fibrosis: the Cardiovascular Health Study.Circulating Biomarkers Predictive of Postoperative Atrial Fibrillation.Targeting inflammatory pathways in myocardial infarction.Standardized Chinese Formula Xin-Ke-Shu inhibits the myocardium Ca(2+) overloading and metabolic alternations in isoproterenol-induced myocardial infarction ratsProcollagen III N-terminal propeptide and desmosine are released by matrix destruction in pulmonary tuberculosisInflammatory cell infiltrates in the heart of patients with coronary artery disease with and without inflammatory rheumatic disease: a biopsy study.Electrical homogenization of ventricular scar by application of collagenase: a novel strategy for arrhythmia therapy.Biomarkers in acutely decompensated heart failure with preserved or reduced ejection fraction.Optimization and comparison of myocardial T1 techniques at 3T in patients with aortic stenosis.The Relationship of Myocardial Collagen Metabolism and Reverse Remodeling after Cardiac Resynchronization TherapyEnhanced store-operated Ca2+ influx and ORAI1 expression in ventricular fibroblasts from human failing heart.From aldosteronism to oxidative stress: the role of excessive intracellular calcium accumulation.Risk stratification and short-term prognosis in acute heart failure syndromes: a review of novel biomarkers.Novel imaging techniques for diffuse myocardial fibrosis.Parathyroid hormone, a crucial mediator of pathologic cardiac remodeling in aldosteronism.
P2860
Q28258044-7B75EE01-2695-424E-BF05-8AE7F4A5F9A8Q33676034-6FC6E2E6-092B-45CB-AEA1-9AA2A412C14FQ33732614-0526B625-C916-4B57-9DA8-9F7E42B62F6DQ33773332-9F3FB600-EE68-4EAA-B95B-D9B2F6B7870DQ33973013-39B1797F-B77A-4F76-9EDB-1470940E4254Q34076151-B0178B4A-AC77-44F0-A638-819A0ACA9E0EQ34140378-76884B71-4D5B-4FDF-B092-55FC84F7BF8AQ34499585-94614769-EE0A-4556-90C2-2C11038085BCQ34533063-53F6AC2B-5EDE-462C-8AA2-BFB7EF8E8D4CQ34587023-A98A7EC4-A40F-4E5D-AFF8-E7FF8E1224EBQ34629550-8AC2F824-AB52-438D-A068-A5191CDA0B0FQ34664894-A81A1530-4031-4182-AC96-FE433D63C668Q34809985-C311BD59-6211-4211-973B-4A77D530071CQ34822562-24846D17-F884-4DC6-AFFA-2A1E386B316FQ35113410-D9D7686A-F228-47D1-A986-E8C7F8FD66FAQ35386272-F507FA89-B86B-4507-81F9-DFBC5FFAB0EAQ35529656-58282302-ABA7-4ED4-9400-6C3CA3465406Q35777180-2643B027-4140-491C-828E-4EC08DCD5BA7Q35846820-7173BA0F-23A4-4532-9180-EBBDB82C9E20Q36012175-64187B8B-3171-4940-90E2-011E2DBF4BFBQ36085814-73515CB9-BF87-4454-8F9A-BC885FB03466Q36171255-B3C93135-62AC-4C88-9CAE-EB1D91BC667EQ36753619-B291B9A8-04D8-4ED2-B6B8-C063BA462CACQ36935635-61F5663D-E0C2-421C-9B54-23F895BF0EF8Q37076096-E0EB2CF6-871D-4A59-B991-F1A4364A1400Q37082373-F76D378C-2AEF-4468-98DB-8B6A624D2831Q37094015-E634807A-F651-4109-BB78-3176F7CAD25BQ37100838-EF7F1BE5-D2F1-4979-9935-B63EC8D7495DQ37125270-A4FC4A75-3E5F-4772-902F-96AAC890843DQ37247445-9D1231B2-F153-4E6C-92AD-7DA6CD42D069Q37330955-E08BC73C-E921-4664-AF77-576E2F9A11C2Q37413056-ADB67029-E642-4F17-9243-2CFC602AC35BQ37419451-2D2E84E3-760C-44D1-9B58-B3AF9F1A14C1Q37691774-CD21B395-2D98-4D6F-BBC3-63C456474B57Q37694908-D59D7CC1-80C2-42ED-8377-F6475AD75543Q37731285-82E4F1EE-D6CC-4008-9313-16BD03AA76F4Q37786549-CB64B34B-47B8-496B-99CB-9EF12A52C868Q37870921-ECA68999-8A69-41BD-9AF6-1708DF2E82BEQ37934994-3ABD4BC2-460E-40C1-ADEC-462A7DCFE7F2Q37988979-DD71EBAF-9A17-4CAA-A2F3-D71A25044E24
P2860
Circulating biomarkers of collagen metabolism in cardiac diseases.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Circulating biomarkers of collagen metabolism in cardiac diseases.
@en
Circulating biomarkers of collagen metabolism in cardiac diseases.
@nl
type
label
Circulating biomarkers of collagen metabolism in cardiac diseases.
@en
Circulating biomarkers of collagen metabolism in cardiac diseases.
@nl
prefLabel
Circulating biomarkers of collagen metabolism in cardiac diseases.
@en
Circulating biomarkers of collagen metabolism in cardiac diseases.
@nl
P1433
P1476
Circulating biomarkers of collagen metabolism in cardiac diseases.
@en
P2093
Arantxa González
Javier Díez
P304
P356
10.1161/CIRCULATIONAHA.109.912774
P407
P50
P577
2010-04-01T00:00:00Z